help_outline Skip to main content
HomeTrainingIFB: The Opioid Epidemic: The Neurobiology of Addiction and the Effects on Insurance

Training - Event View

This is the "Event Detail" view, showing all available information for this event. If registration is required or recommended, click the 'Register Now' button to start the process. If the event has passed, click the "Event Report" button to read a report and view photos that were uploaded.

IFB: The Opioid Epidemic: The Neurobiology of Addiction and the Effects on Insurance

Tuesday, October 29, 2019, 8:30 AM until 12:00 PM
Boston Marriott Newton
2345 Commonwealth Avenue
Newton, MA  02466

(617) 969-1000
Registration is required
presents a half-day seminar on

The Opioid Epidemic: The Neurobiology of Addiction and the Effects on Insurance

DATE: Tuesday, October 29, 2019
TIME: 8:30 am – Noon (registration begins at 7:30 am)
LOCATION: Boston Marriott Newton
2345 Commonwealth Avenue, Auburndale, MA 02466
(617) 969-1000   

PRICE: $45.00  per person (includes continental breakfast) Late registration is $70.00.
SPACE IS LIMITED:  Registration at the door will not be accepted
REGISTRATION: Register on-line by clicking Register button at top right.

Registrations must be received by Friday, October 18, 2019

Please share this page with other interested parties in your organization.


Please join Dr. Dan L. Hunt, D.O., Corporate Medical Director for workers’ compensation insurance carrier AF Group, as he presents about the major factors responsible for the opioid epidemic in America. What happens to the structure and function of the addicted brain? Can we explain and predict an addict’s behavior?  And finally, is there hope for the future?
Dr. Hunt currently works at AF Group’s National Headquarters in Lansing, Michigan. Dr. Hunt practiced as a General Surgeon in Michigan for 28 years prior to joining AF Group in 2014. His current areas of interest are evidence-based medicine; prescription drug monitoring programs; understanding the appropriate roles of opioids, marijuana and alternative treatments for pain in workers compensation; telemedicine; and the impact of wearable monitoring devices on the care of injured workers. 
Dr. Hunt has presented on these topics before the U.S. Food and Drug Administration, Department of Labor, National Prescription Drug Abuse Conference, International Association of Industrial Accident Boards and Commissions (IAIABC), National Insurance Crime Bureau (NICB), American Insurance Association (AIA) and numerous legislative and university groups.  His most recent papers were published in the Journal of Occupational and Environmental Medicine in May of 2016 regarding the effects of evidence-based medicine on the outcomes of injured workers and May of 2019 regarding The Association of Opioid, Anti-Depressant and Benzodiazepines with Workers’ Compensation Cost.
For further information, please contact Deborah Terry or check
Telephone (857) 206-7719   ∙